pe
pep-10355 v1 CC-BY-SA-4.0

Experimental GLP-1 peptide (CHEMBL1222086)

A lab-made peptide that switches on the same gut hormone receptor as blockbuster weight-loss drugs like Ozempic, still experimental, not an approved medicine.

statusbioassayed targetGLP-1R length27 aa refs6
EARLY ENTRY This candidate is newly indexed — supporting evidence is still being added. Have a paper or data point? Contribute below.
status 5 / 5
prediction metrics openfold3-mlx 0.3.1
ipTM0.877
pTM0.757
avg pLDDT53.7
ranking score0.935
STRUCTURE · PEP-10355 × GLP-1R
ranking0.935
target interface 4.5Å peptide drag rotate · ctrl+scroll zoom · right-click pan
openfold3-mlx 0.3.1 · mmCIF ↓ download
sequence27 aa
151015202527
QGTFTSDYS KYLDEQAAK EFIAWLVKG
in the news 136 articles
details expand to inspect
full evidence table1 metrics
metricvaluetool
EC50 0.015 nM GPCRDB/ChEMBL
3-letter notation
Gln-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Lys-Tyr-Leu-Asp-Glu-Gln-Ala-Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Lys-Gly
recipeopenfold3-mlx 0.3.1
parametervalue
modelopenfold3-mlx 0.3.1
weights
hardwareapple_m4_base_16gb
mlx version
python
random seed
msa strategycolabfold
diffusion samples1
runtime419s
predicted bymlx@peptide
predicted at2026-04-25
citationbibtex
peptidemodel (2026). Experimental GLP-1 peptide (CHEMBL1222086) (pep-10355, v1). PeptideModel. https://peptidemodel.com/card/pep-10355
@peptide{pep10355,
  sequence = {QGTFTSDYSKYLDEQAAKEFIAWLVKG},
  target   = {glp-1r},
  author   = {peptidemodel},
  year     = {2026},
  status   = {bioassayed}
}
related peptides 5 by signal overlap
clinical trials 0 trials · checked 2026-05-22
0
no registered clinical trials as of 2026-05-22; we'll re-check periodically
references 6 papers
discussion no comments
sign in to comment
peptidemodel.com CC-BY-SA-4.0 research only · not for human use